Exact Sciences buy Benchmark Co.
Start price
15.03.23
/
50%
€59.64
Target price
15.03.24
€73.83
Performance (%)
-10.85%
End price
16.03.24
€53.17
Summary
This prediction ended on 16.03.24 with a price of €53.17. The price of Exact Sciences has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.85%. Benchmark_Co_ has a follow-up prediction for Exact Sciences where he still thinks Exact Sciences is a Buy. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exact Sciences | 1.154% | 1.154% | 106.108% |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % |
Comments by Benchmark_Co_ for this prediction
In the thread Exact Sciences diskutieren
Exact Sciences Co. (NASDAQ: EXAS) had its price target raised by analysts at Benchmark Co. from $54.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
In the thread Trading Exact Sciences
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten

